 DARTMOUTH, Nova Scotia CAMBRIDGE, Mass.--BUSINESS WIRE--IMV Inc. NASDAQ: IMV; TSX: IMV, a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today announced that members of IMVs executive management team will be participating in person at the H.C. Wainwright Global Investment Conference, which will be held in person and virtually May 23-26, 2022 in Miami, FL. H.C. Wainwright Global Investmen 